Serum uric acid in relation to serum 1,5-anhydroglucitol levels in patients with and without type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Serum uric acid in relation to serum 1,5-anhydroglucitol levels in patients with and without type 2 diabetes mellitus

Published:2013-10 Issue:15 Volume:46 Page:1436-1441
ISSN:0009-9120
Container-title:Clinical Biochemistry
language:en
Short-container-title:Clinical Biochemistry

Author:

Ouchi Motoshi,Oba Kenzo,Aoyama Junya,Watanabe Kentaro,Ishii Kazuhito,Yano Hiroyuki,Motoyama Masayuki,Sekimizu Ken-ichi,Matsumura Noriaki,Igari Yoshimasa,Suzuki Tatsuya,Nakano Hiroshi

Publisher

Elsevier BV

Subject

Clinical Biochemistry,General Medicine

Reference28 articles.

1. Association between serum uric acid and development of type 2 diabetes;Kodama;Diabetes Care,2009

2. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971–1992. National Health and Nutrition Examination Survey;Fang;JAMA,2000

3. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome;Yoo;Circ J,2005

4. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults;Malik;Circulation,2004

5. Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria;Lancet,1999

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship Between 1,5-Anhydroglucitol and Renal Function Assessed by Dynamic Renal Scintigraphy in Type 2 Diabetes;The Journal of Clinical Endocrinology & Metabolism;2024-08-01

2. The correlation between serum 1, 5-anhydroglucitol and β-cell function in Chinese adults with different glucose metabolism statuses;International Journal of Diabetes in Developing Countries;2023-12-12

3. Glycogen storage disease type Ib: modern understanding of the pathogenesis of neutropenia and prospects for its treatment with empagliflozin;Pediatric pharmacology;2023-11-17

4. Current understanding on pathogenesis and effective treatment of glycogen storage disease type Ib with empagliflozin: new insights coming from diabetes for its potential implications in other metabolic disorders;Frontiers in Endocrinology;2023-04-21

5. Understanding the role of SGLT2 inhibitors in glycogen storage disease type Ib: the experience of one UK centre;Orphanet Journal of Rare Diseases;2022-05-12